nderstanding your vulnerabilities
Not Applicable
- Conditions
- Substance use disorder and internalizing symptomsMental and Behavioural Disorders
- Registration Number
- ISRCTN16730956
- Lead Sponsor
- Aarhus University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1. Seeking treatment for substance use disorder
2. Reporting 3 or more points on the Youthmap internalizing problems
Exclusion Criteria
Psychotic disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The expectation of a good outcome measured using the Outcome Expectancies Questionnaire at 1 and 3 months post-randomization<br> <br><br><br>
- Secondary Outcome Measures
Name Time Method 1. Symptoms of anxiety and depression measured using the Depression, Anxiety and Stress Scale - 21 Items (DASS-21) at 1 and 3 months<br>2. Level of functioning measured using the WHO Disability Assessment Schedule-5 (WHODAS-5) at 1 and 3 months<br>3. Knowledge of internalizing symptoms measured using qualitative interviews at the 3-month follow-up<br>4. Retention and treatment attendance measured using an electronic logbook to assess treatment attendance at each session, including no-shows and cancellations. Retention will be measured using time-to-event models at the time of the latest discharge from treatment, or December 31st 2024, whichever occurs first.<br>5. Days abstinent measured using the MapPlan at 1 and 3 months<br>6. Acute psychiatric care measured using both case files and interview data at 1 and 3 months post-randomization